Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 9—September 2013

CME ACTIVITY - Research

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

Amy Parker FiebelkornComments to Author , Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
Author affiliations: Centers for Disease Control and Prevention, Atlanta, GA, USA (A. Parker Fiebelkorn, A.T. Curns, G.S. Wallace); Orange County Health Department, Goshen, New York, USA (J. Lawler, C. Brandeburg)

Main Article

Table 3

Demographic characteristics, median number of months since second MMR vaccine dose, and number of mumps case-patients among household members, Orange County, New York, USA, 2009–2010*

Characteristic


Received 3rd MMR dose as PEP, n = 28


Had 2 previous MMR vaccine doses, received no PEP, n = 77


p value


Sex

M

16 (57.1)

29 (37.7)

0.19

F

12 (42.9)

47 (61.0)

Unknown

0

1 (1.3)

Age, y

4–6

10 (35.7)

21 (27.3)

0.58

7–17

17 (60.7)

50 (64.9)

>18

1 (3.6)

6 (7.8)

Median no. months since 2nd MMR dose, IQR

120 (62–177)

139 (62–210)

0.47

Minimum–maximum no. months

32–468

10–468

Mumps onset, attack rate†


0


4 (5.2)


0.57


*MMR, measles-mumps-rubella vaccine; PEP, postexposure prophylaxis; IQR, interquartile range; values are no. (%) unless otherwise indicated.
†Onset of mumps occurred 12–25 days after onset of mumps in index case-patient.

Main Article

TOP